Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

NCT00914433 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Drug development suspended

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: TPI 1100

Sponsor

Syntara